Natural history of multiple myeloma patients refractory to venetoclax: A single center experience.

Authors :: Maples KT
Nooka AK
Gupta V
Joseph NS
Heffner LT
Hofmeister C
Dhodapkar M
Matulis SM
Lonial S
Boise LH
Kaufman JL
Source :: American journal of hematology [Am J Hematol] 2021 Mar 01; Vol. 96 (3), pp. E68-E71. Date of Electronic Publication: 2020 Dec 28.
Publication Year :: 2021

Subjects :: Adult
Aged
Bridged Bicyclo Compounds, Heterocyclic administration & dosage
Bridged Bicyclo Compounds, Heterocyclic adverse effects
Chromosomes, Human, Pair 11 genetics
Chromosomes, Human, Pair 11 ultrastructure
Chromosomes, Human, Pair 14 genetics
Chromosomes, Human, Pair 14 ultrastructure
Clinical Trials, Phase III as Topic statistics & numerical data
Female
Follow-Up Studies
Humans
Male
Middle Aged
Multiple Myeloma genetics
Multiple Myeloma mortality
Patient Selection
Prognosis
Progression-Free Survival
Sulfonamides administration & dosage
Sulfonamides adverse effects
Translocation, Genetic
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Bridged Bicyclo Compounds, Heterocyclic therapeutic use
Drug Resistance, Neoplasm
Molecular Targeted Therapy
Multiple Myeloma drug therapy
Proto-Oncogene Proteins c-bcl-2 antagonists & inhibitors
Salvage Therapy
Sulfonamides therapeutic use

Full Text Access

Tools